Attached files

file filename
EX-99.2 - EX-99.2 - XENONICS HOLDINGS, INC.d727673dex992.htm
8-K - FORM 8-K - XENONICS HOLDINGS, INC.d727673d8k.htm

Exhibit 99.1

 

LOGO  

Investor Contact:

Berkman Associates

(310) 477-3118

info@BerkmanAssociates.com

 

Company Contact:

Alan Magerman, Chairman

(760) 477-8900

xenonics@xenonics.com

Xenonics Reports Second Quarter Results

CARLSBAD, CALIFORNIA — May 15, 2014 — XENONICS HOLDINGS, INC. (OTCQB:XNNH) today announced financial results for the second quarter and first six months of fiscal 2014.

Revenue for the three months ended March 31, 2014 decreased to $16,000. This compares to revenue of $961,000 for the second quarter of fiscal 2013. The net loss for this year’s second quarter was $576,000, or $0.02 per basic and diluted share. This compares to a net loss for the second quarter of fiscal 2013 of $293,000, or $0.01 per basic and diluted share.

For the six months ended March 31, 2014, revenue decreased to $79,000 compared to $1,118,000 for last year’s first half. The net loss for the first six months of fiscal 2014 was $1,179,000, or $0.05 per basic and diluted share. This compares to a net loss for the first six months of fiscal 2013 of $787,000, or $0.03 per basic and diluted share.

“Approximately $250,000 of orders we had expected to ship in the second quarter were shipped in the third quarter instead. We continue to expect additional significant orders from military and international customers. We currently are in the process of arranging additional financing to support our operations,” said Chairman Alan Magerman.

Conference Call

Xenonics has scheduled a conference call at 11:00 a.m. EDT this morning to discuss its results for the quarter. To participate in the call, dial (800) 510-0146, passcode #16845774. A simultaneous webcast of the conference call can be accessed from the Webcast Center of the Investor Relations link at www.xenonics.com. A replay will be available after 1:00 p.m. EDT at this same Internet address. For a telephone replay, dial (888) 286-8010, passcode #92288381, after 2:00 p.m. EDT.

About Xenonics

Xenonics Holdings, Inc. develops and produces advanced, lightweight and compact ultra-high-intensity illumination and low-light vision products for military, law enforcement, public safety, and commercial and private sector applications. Xenonics’ NightHunter line of illumination products is used by every branch of the U.S. Armed Forces as well as law enforcement and security agencies. Its SuperVision high-definition night vision is designed for commercial and military applications. Employing patented technologies, Xenonics provides innovative solutions for customers who must see farther so they can do their jobs better and safer. Xenonics’ products represent the next generation in small, high intensity, high efficiency illumination and low-light vision systems. Visit Xenonics on the web at www.xenonics.com.

Forward-Looking Statements

Except for the historical statements, statements in this release may constitute forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934. When used, the words “anticipates,” “believes,” “expects,” “intends,” “future,” and other similar expressions identify forward-looking statements. These forward-looking statements reflect management’s current views with respect to future events and financial performance and are subject to risks and uncertainties, and actual results may differ materially from the outcomes contained in any forward-looking statement. Factors that could cause these forward-looking statements to differ from actual results include delays in development, marketing or sales of new products, and other risks and uncertainties discussed in the company’s periodic reports on Form 10-K and 10-Q and other filings with the Securities and Exchange Commission. Xenonics Holdings undertakes no obligation to update or revise any forward-looking statements.

 

   *..*..*..*..*    #49xx

3186 Lionshead Avenue, Carlsbad, CA 92010

(760) 477-8900 fax (760) 477-8896 www.xenonics.com email xenonics@xenonics.com


XENONICS HOLDINGS, INC

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

     Three months ended     Six months ended  
     March 31,     March 31,  
     2014     2013     2014     2013  
Rounded to the nearest thousand, except per share amounts    (unaudited)     (unaudited)  

Revenues

   $ 16,000     $ 961,000     $ 79,000     $ 1,118,000   

Cost of goods sold

     6,000       505,000       44,000       580,000  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     10,000       456,000       35,000       538,000  

Selling, general and administrative

     384,000       468,000       799,000       884,000  

Research and development

     101,000       108,000       229,000       227,000  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from operations

     (475,000     (120,000     (993,000     (573,000

Other income/(expense):

        

Interest (expense)

     (101,000     (173,000     (184,000     (212,000
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before provision for income taxes

     (576,000     (293,000     (1,177,000     (785,000

Income tax provision

     —         —         2,000       2,000  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (576,000   $ (293,000   $ (1,179,000   $ (787,000
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share:

        

Basic and fully-diluted

   $ (0.02   $ (0.01   $ (0.05   $ (0.03
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding:

        

Basic and fully-diluted

     24,976,000       24,976,000       24,976,000       24,976,000  
  

 

 

   

 

 

   

 

 

   

 

 

 


XENONICS HOLDINGS, INC

CONDENSED CONSOLIDATED BALANCE SHEETS

 

     March 31,     September 30,  
     2014     2013  
Rounded to the nearest thousand, except par value    (unaudited)        
Assets     

Current Assets:

    

Cash

   $ 4,000     $ 220,000  

Accounts receivable

     1,000       30,000  

Inventories

     1,121,000       1,154,000  

Other current assets

     35,000       27,000  
  

 

 

   

 

 

 

Total Current Assets

     1,161,000       1,431,000  

Inventories

     480,000       480,000  

Equipment, furniture and fixtures at cost, net

     7,000       11,000  

Goodwill

     375,000       375,000  

Other assets

     17,000       17,000  
  

 

 

   

 

 

 

Total Assets

   $ 2,040,000     $ 2,314,000  
  

 

 

   

 

 

 
Liabilities and Shareholders’ Deficit     

Current Liabilities:

    

Accounts payable

   $ 591,000     $ 399,000  

Accrued expenses

     357,000       211,000  

Accrued payroll and related taxes

     168,000       91,000  

Notes payable, net of debt discount

     2,383,000       —    
  

 

 

   

 

 

 

Total Current Liabilities

     3,499,000       701,000  

Notes payable

     —         1,962,000  
  

 

 

   

 

 

 

Total Liabilities

     3,499,000       2,663,000  
  

 

 

   

 

 

 

Commitments and contingencies

    

Shareholders’ Deficit:

    

Preferred shares, $0.001 par value, 5,000,000 shares authorized, 0 shares issued and outstanding

     —         —    

Common shares, $0.001 par value, 50,000,000 shares authorized; 24,976,000 shares issued and outstanding at March 31, 2014 and September 30, 2013

     25,000       25,000  

Additional paid-in capital

     26,947,000       26,879,000  

Accumulated deficit

     (28,431,000     (27,253,000
  

 

 

   

 

 

 

Total Shareholders’ Deficit

     (1,459,000     (349,000
  

 

 

   

 

 

 

Total Liabilities and Shareholders’ Deficit

   $ 2,040,000     $ 2,314,000